Skip to content
← Catalog

Claim · LNP targeting moieties and lipid chemistry steer in vivo biodistribution · enabling cell-type-specific delivery

Two 2026 PubMed-indexed studies establish that LNP design choices (ionizable lipid chemistry · surface-conjugated targeting moieties) materially alter biodistribution and target-cell transduction in vivo · Guo/Li (ACS Nano 2026 · PMID 42130331) developed β-hydroxy thioether-deri…

Type
claim
Domain
car-t
Grade
conference
License
LIGHT_HOPE_proprietary
Provenance
m622_synthesis_round_8_2026-05-16
evidence_grade
A
category
lnp_biodistribution_targeting_claim
status
verified
instance_tag
sunvax-antibody-2025
clinical_claim_softening
"Synthesis claim · preclinical animal model evidence · technical feasibility anchor · not human clinical outcome data · not intended to guide individual patient treatment choices"
claim_statement
Two 2026 PubMed-indexed studies establish that LNP design choices (ionizable lipid chemistry · surface-conjugated targeting moieties) materially alter biodistribution and target-cell transduction in vivo · Guo/Li (ACS Nano 2026 · PMID 42130331) developed β-hydroxy thioether-deriv
claim_evidence_grade
A
supporting_papers
m622-b5-paper-acsnano-spleen-tropic-2026-001,m622-b5-paper-jcr-multivalent-lnp-2026-001,m622-b5-paper-fap-car-tlnp-2026-001,m622-b5-paper-cancers-review-2025-001
View at source ↗

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.